- Home
- FFAI vs COYA Comparison
FFAI vs COYA Comparison
Compare FFAI & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FFAI
- COYA
- Stock Information
- Founded
- FFAI 2014
- COYA 2020
- Country
- FFAI United States
- COYA United States
- Employees
- FFAI N/A
- COYA N/A
- Industry
- FFAI
- COYA Biotechnology: Pharmaceutical Preparations
- Sector
- FFAI
- COYA Health Care
- Exchange
- FFAI NYSE
- COYA Nasdaq
- Market Cap
- FFAI 111.5M
- COYA 99.8M
- IPO Year
- FFAI N/A
- COYA 2022
- Fundamental
- Price
- FFAI $2.05
- COYA $6.05
- Analyst Decision
- FFAI
- COYA Strong Buy
- Analyst Count
- FFAI 0
- COYA 4
- Target Price
- FFAI N/A
- COYA $16.50
- AVG Volume (30 Days)
- FFAI 12.0M
- COYA 66.5K
- Earning Date
- FFAI 08-13-2025
- COYA 08-11-2025
- Dividend Yield
- FFAI N/A
- COYA N/A
- EPS Growth
- FFAI N/A
- COYA N/A
- EPS
- FFAI N/A
- COYA N/A
- Revenue
- FFAI $853,000.00
- COYA $3,685,107.00
- Revenue This Year
- FFAI $115,335.99
- COYA $106.97
- Revenue Next Year
- FFAI N/A
- COYA N/A
- P/E Ratio
- FFAI N/A
- COYA N/A
- Revenue Growth
- FFAI 8.52
- COYA N/A
- 52 Week Low
- FFAI $0.83
- COYA $4.65
- 52 Week High
- FFAI $21.89
- COYA $10.24
- Technical
- Relative Strength Index (RSI)
- FFAI N/A
- COYA 54.81
- Support Level
- FFAI N/A
- COYA $5.97
- Resistance Level
- FFAI N/A
- COYA $6.45
- Average True Range (ATR)
- FFAI 0.00
- COYA 0.37
- MACD
- FFAI 0.00
- COYA 0.04
- Stochastic Oscillator
- FFAI 0.00
- COYA 54.70
About FFAI FARADAY FUTURE INTELLIGENT ELEC INC
Faraday Future Intelligent Electric Inc is a shared intelligent mobility ecosystem. The company is poised to break the boundaries between the Internet, IT, creative, and auto industries with product and service offerings that integrate new energy, AI, Internet, and sharing models. The company has additional engineering, sales, and operational capabilities in China and plans to develop its manufacturing capability in China through a joint venture.
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.